Higher sales of fine-particle polymers and other products, with profit pressure from the stronger yen
First written in FY2017-Q1. 9 of 32 entries say "Restated". Latest entry: 2026-08-06.
The whole theme swung hardest in 2019: 2 of 18 companies on the "Worse" side.
6 other companies' latest entry also says "Advanced".
- 2026-08-06AdvancedRevisions to earnings forecasts
「Net sales and profit increased from the same period of the previous year, owing in part to expanded sales of water-soluble polymers and PSA hydrogen-generation equipment.」
In the Functional Materials segment, expanded sales of water-soluble polymers and PSA hydrogen-generation equipment were specifically cited as factors behind higher sales and profit. The canonical thread remains unchanged. - FY2026AdvancedAnnual report
「Although the end of the IR latex business in the previous fiscal year had an impact, revenue was in line with the previous fiscal year and operating profit increased due mainly to expanded sales of water-soluble polymers and PSA oxygen generators.」
While the impact of the end of the IR latex business remained, operating profit in Functional Materials increased 11.0% year on year due to expanded sales of water-soluble polymers and PSA oxygen generators. - FY2026-H1Higher water-soluble polymer sales volumes offset by lower revenue and earnings following the end of the IR latex businessAnnual report
「Sales volumes of water-soluble polymers increased, but revenue and earnings declined due to the end of the IR latex business during the fiscal year ending March 2025 and higher fixed costs.」
Although sales volumes of water-soluble polymers increased, the Functional Materials segment reported lower revenue and earnings due to the end of the IR latex business and higher fixed costs. - FY2025-H1Higher earnings despite lower IR latex sales volumes due to lower raw material and fuel pricesAnnual report
「Revenue declined mainly due to lower sales volumes of IR latex and other factors, while operating profit increased due mainly to lower raw material and fuel prices and foreign exchange effects.」
In the Functional Materials segment, revenue declined due to lower sales volumes of IR latex, while operating profit increased due mainly to lower raw material and fuel prices and other factors. - FY2024-Q3RestatedAnnual report
「This was due mainly to lower sales volumes of electronic gases, latex products and pharmaceutical intermediates, as well as higher fixed costs and other factors.」
In the Functional Materials segment, lower sales volumes of electronic gases, latex products and pharmaceutical intermediates and higher fixed costs continue to be cited as factors behind the year-on-year earnings decline. - FY2024-Q2RestatedAnnual report
「This was due mainly to lower sales volumes of electronic gases, latex products and pharmaceutical intermediates, as well as higher fixed costs and other factors.」
Lower sales volumes of Functional Materials products and higher fixed costs continue to be cited as factors behind lower earnings in the segment, following FY2024-Q1. - FY2024-Q1Lower sales volumes of Functional Materials products and higher fixed costsAnnual report
「This was due mainly to lower sales volumes of electronic gases, pharmaceutical intermediates, latex products and other products, as well as higher fixed costs and other factors.」
For Functional Materials products, which had been listed among the products driving sales volume growth through the previous fiscal year, lower sales volumes of electronic gases, pharmaceutical intermediates and latex products and higher fixed costs were cited as factors behind lower earnings. - FY2023-Q3Battery materials added among products driving sales growthAnnual report
「This was due mainly to higher sales volumes of electronic gases, water-soluble polymers and battery materials, as well as foreign exchange effects and other factors.」
In the Functional Materials segment, in addition to the previously cited electronic gases and water-soluble polymers, higher sales volumes of battery materials were specifically identified as a factor behind higher revenue and earnings. - FY2023-Q2RestatedAnnual report
「This was due mainly to higher sales volumes of electronic gases, water-soluble polymers and functional products, as well as foreign exchange effects and other factors.」
In the Functional Materials segment, higher sales volumes of electronic gases, water-soluble polymers and functional products continued to be cited as factors behind higher revenue and earnings, following the previous quarter. - FY2023-Q1Products driving sales growth changed to electronic gases, water-soluble polymers and functional productsAnnual report
「This was due mainly to higher sales volumes of electronic gases, water-soluble polymers and functional products, as well as foreign exchange effects and other factors.」
In the Functional Materials segment, higher sales volumes of electronic gases, water-soluble polymers and functional products were cited as factors behind higher revenue and earnings. - FY2022RestatedAnnual report
「This was due mainly to higher sales volumes of pharmaceutical intermediates, functional products and powder resins, as well as foreign exchange effects and other factors.」
In the Functional Chemicals segment, higher sales volumes of pharmaceutical intermediates, functional products and powder resins were cited as factors behind higher revenue and earnings for the full fiscal year. - FY2022-Q3Functional products added among products driving sales growthAnnual report
「This was due mainly to higher sales volumes of pharmaceutical intermediates, functional products and powder resins.」
In addition to higher sales volumes of pharmaceutical intermediates and powder resins, higher sales volumes of functional products were specifically identified as a factor behind higher earnings in the Functional Chemicals segment. - FY2022-Q2RestatedAnnual report
「This was due mainly to higher sales volumes of pharmaceutical intermediates, latex products and powder resins.」
Higher sales volumes of pharmaceutical intermediates, latex products and powder resins continued to be cited as factors behind higher revenue and earnings in the Functional Chemicals segment. - FY2022-Q1Powder resins added among products driving sales growthAnnual report
「This was due mainly to higher sales volumes of pharmaceutical intermediates, latex products and powder resins.」
In addition to the previously cited water-soluble polymers, microparticle polymers, latex products and pharmaceutical intermediates, higher sales volumes of powder resins were cited as factors behind higher revenue and earnings in the Functional Chemicals segment. - FY2021Products driving sales growth changed to latex products and pharmaceutical intermediatesAnnual report
「This was due mainly to higher sales volumes of latex products and pharmaceutical intermediates.」
In addition to the previously cited water-soluble polymers and microparticle polymers, higher sales volumes of latex products and pharmaceutical intermediates were cited this fiscal year as factors behind higher revenue and earnings in Functional Chemicals. - FY2021-Q3Reference to lower sales volumes of functional products removed, leaving only products driving sales growthAnnual report
「This was due mainly to higher sales volumes of water-soluble polymers and microparticle polymers.」
The lower sales volumes of functional products and other products, which had been listed through the previous quarter, were not mentioned in the explanation for the current quarter, while higher sales volumes of water-soluble polymers and microparticle polymers were cited. - FY2021-Q2Lower sales volumes of functional products listed alongside products driving sales growthAnnual report
「This was due mainly to higher sales volumes of microparticle polymers, water-soluble polymers and other products, despite lower sales volumes of functional products and other products.」
While higher sales volumes of microparticle polymers and water-soluble polymers continued, lower sales volumes of functional products and other products were also cited this time as factors behind lower revenue and earnings in the Functional Chemicals segment. - FY2021-Q1Microparticle polymers reappear among products driving sales growthAnnual report
「This was due mainly to higher sales volumes of water-soluble polymers and microparticle polymers.」
The description changed from sales volumes being in line with the year-earlier quarter from the end of the previous fiscal year through the first quarter of the current fiscal year to higher sales volumes of water-soluble polymers and microparticle polymers. - FY2020-Q3From higher sales volumes to levels in line with the year-earlier quarterAnnual report
「Revenue was at a level in line with the year-earlier quarter, while operating profit declined due mainly to higher R&D expenses and other factors.」
The description changed from higher sales volumes of emulsion products and other products, which had been specifically identified in the previous quarter, to revenue being in line with the year-earlier quarter. Meanwhile, the decline in operating profit due to higher R&D expenses continues. - FY2020-Q2Emulsion products specifically identified among products driving sales growthAnnual report
「Revenue increased due to higher sales volumes of emulsion products and other products, while operating profit declined due mainly to higher R&D expenses and other factors.」
Although the pattern of higher R&D expenses driving lower earnings continued, emulsion products were specifically identified among the products driving sales volume growth. - FY2020-Q1From sales-related factors to lower earnings due to higher R&D expensesAnnual report
「Revenue increased, while operating profit declined due mainly to higher R&D expenses and other factors.」
In the Chemicals segment, higher R&D expenses, rather than changes in sales volumes by product, were cited as a factor behind the decline in operating profit. - FY2019-Q3RestatedAnnual report
「This was due mainly to higher sales volumes of water-soluble polymers, pharmaceutical intermediates and other products.」
In the Chemicals segment, higher sales volumes of water-soluble polymers, pharmaceutical intermediates and other products continue to be cited as factors behind year-on-year revenue and earnings growth. - FY2019-Q2Expansion of products driving sales volume growthAnnual report
「This was due mainly to higher sales volumes of water-soluble polymers, pharmaceutical intermediates and other products.」
In the Chemicals segment, higher sales volumes of pharmaceutical intermediates, in addition to water-soluble polymers, are cited as factors behind higher revenue and earnings. - FY2019-Q1Change in products driving sales volume growthAnnual report
「This was due to higher sales volumes of water-soluble polymers and other products.」
In the Chemicals segment, higher sales volumes of water-soluble polymers and other products are cited as factors behind higher revenue and earnings, changed from the previously cited microparticle polymers and other products. - FY2018RestatedAnnual report
「This was due mainly to higher shipments of microparticle polymers and other products, despite lower sales of pharmaceutical products.」
Higher shipments of microparticle polymers and other products and lower sales of pharmaceutical products are cited as factors affecting the Chemicals segment's performance. - FY2018-Q3Sales volumes changed from flat to increasingAnnual report
「This was due mainly to higher sales volumes of microparticle polymers and other products, despite lower sales volumes of medical products.」
Sales volumes of microparticle polymers and other products changed from being in line with the year-earlier quarter in the previous quarter to increasing. Meanwhile, lower sales volumes of medical products continue to be cited as a factor behind the earnings decline in the Chemicals segment. - FY2018-Q2Fine-particle polymer sales volumes changed from an increase to being flatAnnual report
「This was attributable to sales volumes of fine-particle polymers and other products being broadly in line with the same period of the previous fiscal year, while sales volumes of pharmaceutical products declined, among other factors.」
Sales volumes of fine-particle polymers and other products changed from the previous increase to being broadly in line with the same period of the previous fiscal year, while lower sales volumes of pharmaceutical products were cited as a factor driving lower net sales and profit in the Chemicals segment. - FY2018-Q1Change in factors driving lower profitAnnual report
「This was attributable to increased sales of fine-particle polymers and other products, while sales volumes of pharmaceutical products and other products declined.」
Although sales of fine-particle polymers and other products continued to increase, lower sales volumes of pharmaceutical products and other products, rather than the previously cited stronger yen, were cited as factors driving lower net sales and profit in the Chemicals segment. - FY2017RestatedAnnual report
「This was attributable to the impact of terminating certain resale businesses at a domestic consolidated subsidiary, despite increased sales volumes of fine-particle polymers and other products, among other factors.」
Despite increased sales volumes of fine-particle polymers and other products, the Chemicals segment reported lower net sales and profit due to the impact of terminating the resale businesses. - FY2017-Q3Change in factors driving lower profitAnnual report
「This was attributable to the impact of terminating certain resale businesses at a domestic consolidated subsidiary, despite increased sales volumes of fine-particle polymers and other products, among other factors.」
Although sales volumes of fine-particle polymers and other products increased, net sales and operating profit in the Chemicals segment fell below the same period of the previous fiscal year. The termination of certain resale businesses, rather than the previously cited stronger yen, was cited as the factor driving the decline. - FY2017-Q2RestatedAnnual report
「This was attributable to increased sales of fine-particle polymers and other products.」
In the Chemicals segment, net sales and operating profit exceeded the same period of the previous fiscal year due to increased sales of fine-particle polymers and other products. - FY2017-Q1First statedAnnual report
「This was attributable to increased sales of fine-particle polymers and other products, while the yen remained stronger year on year, among other factors.」
In the Chemicals segment, operating profit declined year on year due to the stronger yen and other factors, despite higher sales.